Y. Abe, A. Kawakami, T. Nakashima, E. Ejima, K. Fujiyama et al., Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells, Journal of Laboratory and Clinical Medicine, vol.136, issue.5, pp.344-54, 2000.
DOI : 10.1067/mlc.2000.109757

B. Baumann and T. Wronski, Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats, Bone, vol.16, issue.2, pp.247-53, 1995.
DOI : 10.1016/8756-3282(94)00036-Y

D. Bikle, E. Morey-holton, S. Doty, P. Currier, S. Tanner et al., Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage, Journal of Bone and Mineral Research, vol.6, issue.11, pp.1777-87, 1994.
DOI : 10.1002/jbmr.5650091115

D. Black, S. Greenspan, K. Ensrud, L. Palermo, J. Mcgowan et al., The Effects of Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis, New England Journal of Medicine, vol.349, issue.13, pp.1207-1222, 2003.
DOI : 10.1056/NEJMoa031975

G. Boivin, P. Chavassieux, A. Santora, J. Yates, and P. Meunier, Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women, Bone, vol.27, issue.5, pp.687-94, 2000.
DOI : 10.1016/S8756-3282(00)00376-8

H. Bone, D. Hosking, J. Devogelaer, J. Tucci, R. Emkey et al., Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women, New England Journal of Medicine, vol.350, issue.12, pp.1189-99, 2004.
DOI : 10.1056/NEJMoa030897

D. Burr, Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size, Current Osteoporosis Reports, vol.19, issue.1, pp.19-24, 2005.
DOI : 10.1007/s11914-005-0023-9

D. Burr, L. Miller, M. Grynpas, J. Li, A. Boyde et al., Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs, Bone, vol.33, issue.6, pp.960-969, 2003.
DOI : 10.1016/j.bone.2003.08.004

P. Chavassieux, M. Arlot, C. Reda, L. Wei, A. Yates et al., Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis., Journal of Clinical Investigation, vol.100, issue.6, pp.1475-80, 1997.
DOI : 10.1172/JCI119668

F. Coxon, M. Helfrich, B. Larijani, M. Muzylak, J. Dunford et al., Identification of a novel phosphonocarboxylate inhibitor of rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages, J Biol Chem, vol.276, pp.48213-48235, 2001.

F. Coxon, F. Ebentino, E. Mules, M. Seabra, C. Mckenna et al., Phosphonocarboxylate inhibitors of Rab geranylgeranyl transferase disrupt the prenylation and membrane localization of Rab proteins in osteoclasts in vitro and in vivo, Bone, vol.37, issue.3, pp.349-58, 2005.
DOI : 10.1016/j.bone.2005.04.021

F. Coxon, K. Thompson, F. Ebetino, and M. Rogers, Resorbing osteoclasts increase the availability of mineral-bound bisphosphonates to nonresorbing cells, J Bone Miner Res, vol.20, p.260, 2005.

F. Coxon, K. Thompson, A. Hughes, F. Ebetino, and M. Rogers, Risedronate and other nitrogen-containing bisphosphonates are efficiently internalized from mineralized surfaces by osteoclasts, but not other cell types, in vitro and in vivo, Bone, vol.36, p.303, 2005.

B. Ettinger, S. Martin, J. Crans, G. Pavo, and I. , Differential Effects of Teriparatide on BMD After Treatment With Raloxifene or Alendronate, Journal of Bone and Mineral Research, vol.18, issue.5, pp.745-51, 2004.
DOI : 10.1359/jbmr.040117

J. Finkelstein, A. Hayes, J. Hunzelman, J. Wyland, H. Lee et al., The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis, New England Journal of Medicine, vol.349, issue.13, pp.1216-1242, 2003.
DOI : 10.1056/NEJMoa035725

J. Fisher, G. Rodan, and A. Reszka, Effects of Bisphosphonates on the Osteoclast Mevalonate Pathway, Endocrinology, vol.141, issue.12, pp.4793-4799, 2000.
DOI : 10.1210/endo.141.12.7921

H. Follet, G. Boivin, C. Rumelhart, and P. Meunier, The degree of mineralization is a determinant of bone strength: a study on human calcanei, Bone, vol.34, issue.5, pp.783-792, 2004.
DOI : 10.1016/j.bone.2003.12.012

URL : https://hal.archives-ouvertes.fr/inserm-00557244

B. Frediani, A. Spreafico, C. Capperucci, F. Chellini, D. Gambera et al., Long-term effects of neridronate on human osteoblastic cell cultures, Bone, vol.35, issue.4, pp.859-69, 2004.
DOI : 10.1016/j.bone.2004.06.001

O. Fromigue and J. Body, Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts, Journal of Endocrinological Investigation, vol.104, issue.6, pp.539-585, 2002.
DOI : 10.1007/BF03345497

C. Garcia-moreno, S. Serrano, M. Nacher, M. Farre, A. Diez et al., Effect of alendronate on cultured normal human osteoblasts, Bone, vol.22, issue.3, pp.233-242, 1998.
DOI : 10.1016/S8756-3282(97)00270-6

J. Gasser, P. Ingold, A. Rebmann, and M. Susa, The blunting of the bone anabolic response to PTH observed after frequently dosed bisphosphonates in rats may be explained by inhibition of farnesyl diphosphate synthase in osteoblasts, J Bone Miner Res, vol.20, p.78, 2005.

J. Gasser, M. Kneissel, J. Thomsen, and L. Mosekilde, PTH and interactions with bisphosphonates, J Muscloskel Neuron Interact, vol.1, pp.53-59, 2000.

N. Giuliani, M. Pedrazzoni, G. Negri, G. Passeri, M. Impicciatore et al., Bisphosphonates Stimulate Formation of Osteoblast Precursors and Mineralized Nodules in Murine and Human Bone Marrow Cultures In Vitro and Promote Early Osteoblastogenesis in Young and Aged Mice In Vivo, Bone, vol.22, issue.5, pp.455-61, 1998.
DOI : 10.1016/S8756-3282(98)00033-7

A. Hodsman and B. Steer, Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces, Bone, vol.14, issue.3, pp.523-530, 1993.
DOI : 10.1016/8756-3282(93)90190-L

D. Hughes, K. Wright, H. Uy, A. Sasaki, T. Yoneda et al., Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo, Journal of Bone and Mineral Research, vol.11, issue.2, pp.1478-87, 1995.
DOI : 10.1002/jbmr.5650101008

G. Im, S. Qureshi, J. Kenney, H. Rubash, and A. Shanbhag, Osteoblast proliferation and maturation by bisphosphonates, Biomaterials, vol.25, issue.18, pp.4105-4120, 2004.
DOI : 10.1016/j.biomaterials.2003.11.024

M. Khokher and P. Dandona, Diphosphonates inhibit human osteoblast secretion and proliferation, Metabolism, vol.38, issue.2, pp.184-191, 1989.
DOI : 10.1016/0026-0495(89)90260-6

S. Khosla, Parathyroid Hormone plus Alendronate ??? A Combination That Does Not Add Up, New England Journal of Medicine, vol.349, issue.13, pp.1277-1286, 2003.
DOI : 10.1056/NEJMe038143

R. Lindsay, F. Cosman, M. Bosteom, J. Cruz, J. Nieves et al., Short term response to parathyroid hormone (1?34 hPTH) in human iliac crest bone using a unique quadruple (double double) tetracycline labeling regimen and single biopsy, J Bone Miner Res, vol.18, p.54, 2003.

P. Mackie, J. Fisher, H. Zhou, and P. Choong, Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line, British Journal of Cancer, vol.84, issue.7, pp.951-959, 2001.
DOI : 10.1054/bjoc.2000.1679

P. Meunier and G. Boivin, Bone mineral density reflects bone mass but also the degree of mineralization of bone: Therapeutic implications, Bone, vol.21, issue.5, pp.373-380, 1997.
DOI : 10.1016/S8756-3282(97)00170-1

H. Murakami, N. Takahashi, T. Sasaki, N. Udagawa, S. Tanaka et al., A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders, Bone, vol.17, issue.2, pp.137-181, 1995.
DOI : 10.1016/S8756-3282(95)00150-6

M. Nakamura, N. Udagawa, S. Matsuura, M. Mogi, H. Nakamura et al., Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption, Endocrinology, vol.144, issue.12, pp.5441-5450, 2003.
DOI : 10.1210/en.2003-0717

A. Parfitt, M. Drezner, F. Glorieux, J. Kanis, H. Malluche et al., Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee, Journal of Bone and Mineral Research, vol.10, issue.6, pp.595-610, 1987.
DOI : 10.1002/jbmr.5650020617

L. Plotkin, R. Weinstein, A. Parfitt, P. Roberson, S. Manolagas et al., Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin, Journal of Clinical Investigation, vol.104, issue.10, pp.1363-74, 1999.
DOI : 10.1172/JCI6800

R. Recker, S. Diem, E. Cheng, S. Bare, P. Masarachia et al., Normal bone histomorphometry and 3D microarchitecture after 10 years alendronate treatment of postmenopausal women, J Bone Miner Res, vol.19, p.45, 2004.

G. Reinholz, B. Getz, L. Pederson, E. Sanders, M. Subramaniam et al., Bisphosphonates directly regulate cell proliferation, differentiation , and gene expression in human osteoblasts, Cancer Res, vol.60, pp.6001-6008, 2000.

G. Rodan and H. Fleisch, Bisphosphonates: mechanisms of action., Journal of Clinical Investigation, vol.97, issue.12, pp.2692-2698, 1996.
DOI : 10.1172/JCI118722

O. Sorensen, G. Crawford, H. Mulder, D. Hosking, C. Gennari et al., Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience??????This study was sponsored by Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, and Aventis Pharma, Bridgewater, New Jersey., Bone, vol.32, issue.2, pp.120-126, 2003.
DOI : 10.1016/S8756-3282(02)00946-8

E. Van-beek, C. Lowik, G. Van-der-pluijm, and S. Papapoulos, The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen-Containing Bisphosphonates, Journal of Bone and Mineral Research, vol.22, issue.Suppl, pp.722-731, 1999.
DOI : 10.1359/jbmr.1999.14.5.722

V. Viereck, G. Emons, V. Lauck, K. Frosch, S. Blaschke et al., Bisphosphonates Pamidronate and Zoledronic Acid Stimulate Osteoprotegerin Production by Primary Human Osteoblasts, Biochemical and Biophysical Research Communications, vol.291, issue.3, pp.680-686, 2002.
DOI : 10.1006/bbrc.2002.6510

F. Von-knoch, C. Jaquiery, M. Kowalsky, S. Schaeren, C. Alabre et al., Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells, Biomaterials, vol.26, issue.34, pp.6941-6950, 2005.
DOI : 10.1016/j.biomaterials.2005.04.059

T. Wronski and C. Yen, Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats, Bone, vol.15, issue.1, pp.51-59, 1994.
DOI : 10.1016/8756-3282(94)90891-5

Z. Zimolo, G. Wesolowski, and G. Rodan, Acid extrusion is induced by osteoclast attachment to bone. Inhibition by alendronate and calcitonin., Journal of Clinical Investigation, vol.96, issue.5, pp.2277-83, 1995.
DOI : 10.1172/JCI118283